OncoSil Medical Ltd
OncoSil Medical Ltd
Your view on OSL.AX
Overview
What the company does, where it operates, and who runs it.
About OncoSil Medical Ltd
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Nigel Lange
- Headquarters
- 7 Eden Park Drive, Macquarie Park, NSW, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Nigel Lange
- Headquarters
- 7 Eden Park Drive, Macquarie Park, NSW, AU
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.
The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for OncoSil Medical Ltd. Starting points for OncoSil Medical Ltd: EPS -AUD 0.40, beta 1.17 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for OncoSil Medical Ltd. OncoSil Medical Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for OncoSil Medical Ltd. Trailing twelve-month EPS for OncoSil Medical Ltd stands at -AUD 0.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for OncoSil Medical Ltd. OncoSil Medical Ltd has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ADMTADM Tronics Unlimited, Inc. | Healthcare | OTC | $6.8M | ||
| ADR.AXAdherium Limited | Healthcare | ASX | — | ||
| AEMDAethlon Medical, Inc. | Healthcare | NASDAQ | $2.7M | ||
| AFIBAcutus Medical, Inc. | Healthcare | OTC | $5,982 | ||
| AHCOAdaptHealth Corp. | Healthcare | NASDAQ | $1.0B | ||
| ALGNAlign Technology, Inc. | Healthcare | NASDAQ | $11.6B | ||
| ALRTFALR Technologies Inc. | Healthcare | OTC | $8.2M | ||
| ALURAllurion Technologies Inc. | Healthcare | OTC | $11.0M | ||
| AMBBYAmbu A/S | Healthcare | OTC | $3.3B | ||
| AMBFFAmbu A/S | Healthcare | OTC | $3.7B | ||
| AMIXAutonomix Medical, Inc. Common Stock | Healthcare | NASDAQ | $592,199 | ||
| AORTArtivion, Inc. | Healthcare | NYSE | $904.6M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for OncoSil Medical Ltd. Coverage tracks OncoSil Medical Ltd within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of OncoSil Medical Ltd.